TRPA1 and migraine disorder: In this scenario, the key role of TRPA1 channels, whose blockade may abolish calcium hyperactivity [63] and all the downstream mechanisms, thus interrupting the positive feedback loop that causes the release of neuroactive peptides (e.g., CGRP) [42] and pro-inflammatory mediators involved in migraine-related pain [77], is evident.